Juvenile myelomonocytic leukemia overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
 
Line 8: Line 8:


{{Hematological malignancy histology}}
{{Hematological malignancy histology}}
{{SIB}}
 


[[Category:Hematology]]
[[Category:Hematology]]

Latest revision as of 16:39, 9 August 2012

Juvenile myelomonocytic leukemia Microchapters

Home

Patient Info

Overview

Historical Perspective

Classification

Pathophysiology

Epidemiology & Demographics

Risk Factors

Screening

Causes of Juvenile myelomonocytic leukemia

Differentiating Juvenile myelomonocytic leukemia from other Diseases

Natural History, Complications & Prognosis

Diagnosis

History & Symptoms

Physical Examination

Lab Tests

Electrocardiogram

Chest X Ray

MRI

CT

Echocardiography or Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgical Therapy

Radiation Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Juvenile myelomonocytic leukemia overview On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Juvenile myelomonocytic leukemia overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Juvenile myelomonocytic leukemia overview

CDC on Juvenile myelomonocytic leukemia overview

Juvenile myelomonocytic leukemia overview in the news

Blogs on Juvenile myelomonocytic leukemia overview

to Hospitals Treating Juvenile myelomonocytic leukemia

Risk calculators and risk factors for Juvenile myelomonocytic leukemia overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Juvenile myelomonocytic leukemia (JMML) is a serious chronic leukemia (cancer of the blood) that affects children mostly aged 4 and under. The average age of patients at diagnosis is 2 years old. The World Health Organization has included JMML in the category of Myelodysplastic and Myeloproliferative disorders.[1] The name JMML now encompasses all diagnoses formerly referred to as Juvenile Chronic Myeloid Leukemia (JCML), Chronic Myelomonocytic Leukemia of Infancy, and Infantile Monosomy 7 Syndrome.

References

  1. "Myelodysplastic/Myeloproliferative Diseases Treatment - National Cancer Institute".

fi:Juveniili myelomonosyyttileukemia


Template:WikiDoc Sources